Skip to content

Clinical trials

Terminated Phase 2/3 trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Finland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20091
20122
20152
20161
20171
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Biohaven Therapeutics Ltd.1
Danisco1
Eli Lilly and Company1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1
Kuopio University Hospital1
Solvay Pharmaceuticals1
Turku University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease3
Bronchiolitis Obliterans Syndrome1
Dementia1
Diabetes Mellitus, Type 21
Drug Resistant Epilepsy1
Dyslipidemias1
Epilepsy1
Epilepsy, Absence1
Epilepsy, Generalized1
Fractures, Bone1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.